Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
+3.2M
-
Total reported value, excl. options
-
$37.5M
-
Value change
-
+$6.56M
-
Number of buys
-
23
-
Number of sells
-
-12
-
Price
-
$2.04
Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q4 2023
49 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 87.4M outstanding shares and own 21.01% of the company stock.
Largest 10 shareholders include FMR LLC (4.75M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), JOSH ARNOLD INVESTMENT CONSULTANT, LLC (1.86M shares), VANGUARD GROUP INC (1.78M shares), BALYASNY ASSET MANAGEMENT L.P. (1.25M shares), Kent Lake Capital LLC (1.09M shares), Triatomic Management LP (885K shares), CINCINNATI INSURANCE CO (700K shares), TIFF ADVISORY SERVICES, LLC (423K shares), and ELEMENT POINTE ADVISORS, LLC (398K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.